Sara Hadjigol

431 total citations
9 papers, 255 citations indexed

About

Sara Hadjigol is a scholar working on Microbiology, Molecular Biology and Immunology. According to data from OpenAlex, Sara Hadjigol has authored 9 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Microbiology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Sara Hadjigol's work include Antimicrobial Peptides and Activities (5 papers), Antimicrobial agents and applications (2 papers) and Immune cells in cancer (2 papers). Sara Hadjigol is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Antimicrobial agents and applications (2 papers) and Immune cells in cancer (2 papers). Sara Hadjigol collaborates with scholars based in Australia and Singapore. Sara Hadjigol's co-authors include Neil M. O’Brien‐Simpson, Wenyi Li, Jason C. Lenzo, James A. Holden, Greg G. Qiao, Mary B. Chan‐Park, Zhangyong Si, Dicky Pranantyo, Anders J. Barlow and Fiona Eyers and has published in prestigious journals such as ACS Applied Materials & Interfaces, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Sara Hadjigol

9 papers receiving 252 citations

Peers

Sara Hadjigol

IMMUN

MB

MICRO

ONCOL

BE

Binyan Zhao China

Michelle Pate United States

Yao Huang China

Andrew Gould United States

Ankit Javia India

Mahere Rezazade Bazaz Iran

Manlong Xu China

Panpan Ji China

Sophia M. Orbach United States

Suhe Dong China

Binyan Zhao China

Sara Hadjigol

63 ×0.5

IMMUN

202 ×2.1

MB

35 ×0.6

MICRO

61 ×1.2

ONCOL

58 ×1.8

BE

Citations per year, relative to Sara Hadjigol Sara Hadjigol (= 1×) peers Binyan Zhao

Countries citing papers authored by Sara Hadjigol

Since Specialization

Citations

This map shows the geographic impact of Sara Hadjigol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Hadjigol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Hadjigol more than expected).

Fields of papers citing papers by Sara Hadjigol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Hadjigol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Hadjigol. The network helps show where Sara Hadjigol may publish in the future.

Co-authorship network of co-authors of Sara Hadjigol

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Hadjigol. A scholar is included among the top collaborators of Sara Hadjigol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Hadjigol. Sara Hadjigol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Holden, James A., et al.. (2025). Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer. npj Vaccines. 10(1). 68–68. 6 indexed citations

2.

Hadjigol, Sara, et al.. (2025). Lipidated SNAPP-Stars Target and Kill Multidrug-Resistant Bacteria within Minutes. ACS Applied Materials & Interfaces. 17(17). 25163–25181. 2 indexed citations

3.

Li, Wenyi, et al.. (2024). Dimerization and lysine substitution of melittin have differing effects on bacteria. Frontiers in Pharmacology. 15. 1443497–1443497. 3 indexed citations

4.

Hadjigol, Sara, Wenyi Li, Zhangyong Si, et al.. (2024). Synthetic peptide branched polymers for antibacterial and biomedical applications. Nature Reviews Bioengineering. 2(4). 343–361. 41 indexed citations

5.

Hadjigol, Sara, et al.. (2022). The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes. Frontiers in Immunology. 13. 894021–894021. 13 indexed citations

6.

Li, Wenyi, et al.. (2022). The Potential of Modified and Multimeric Antimicrobial Peptide Materials as Superbug Killers. Frontiers in Chemistry. 9. 795433–795433. 29 indexed citations

7.

Li, Wenyi, Sara Hadjigol, James A. Holden, et al.. (2022). Star-Peptide Polymers are Multi-Drug-Resistant Gram-Positive Bacteria Killers. ACS Applied Materials & Interfaces. 14(22). 25025–25041. 27 indexed citations

8.

Holden, James A., et al.. (2021). Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting. Frontiers in Oncology. 11. 788365–788365. 112 indexed citations

9.

Hadjigol, Sara, Steven Maltby, Hock L. Tay, et al.. (2019). Lipopolysaccharide induces steroid‐resistant exacerbations in a mouse model of allergic airway disease collectively through IL‐13 and pulmonary macrophage activation. Clinical & Experimental Allergy. 50(1). 82–94. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact